Applied Biosystems has brought out a range of Taqman real-time PCR assays that enable researchers to rapidly detect and quantify proteins in human cell samples.
The Taqman Protein Expression Assays allow researchers to correlate relative levels of specific proteins with cell functions and behaviours, such as different disease conditions, or states of pluripotency or differentiation in stem cells.
The initial release of these molecular tools includes assays that enable relative quantification of protein markers for pluripotency, from limited quantities of cultured human embryonic stem cells.
These new molecular tools offer researchers a more quantitative, simpler and more standardised approach to protein analysis of various cell types, especially stem cells, compared with other more complex methods that require large amounts of cell sample.
The new assays detect and quantify proteins by a technology that combines an antibody-oligonucleotide-tagged immunoassay with a Taqman Assay, to generate real-time PCR data for specific proteins present in as few as 10 to 250 cells.
The initial release of these assays in August will consist of six pre-designed protein expression assays.
Four of the assays target stem-cell pluripotency markers and two target more commonly expressed proteins in a variety of cell types.
When combined with Applied Biosystems' Taqman Assays for microRNA and messenger RNA - run on one of its range of real-time PCR systems - they form a quantitative protein-analysis method that enables researchers to make comparisons of protein and RNA molecular markers identified on the same platform, with the same starting samples.
The new assays for stem-cell targets have already been used by a team of scientists at Erasmus University Medical Center in Rotterdam, The Netherlands, to quantify protein biomarkers for pluripotency, using small quantities of human stem-cell and testicular germ-cell samples.
In a study being presented this week at the International Society for Stem Cell Research (ISSCR) conference in Spain, scientists used the Taqman Protein Expression Assays to analyse germ-cell tumours and derived cell lines to characterise protein biomarkers for stem-cell pluripotency.
These kinds of biomarkers can potentially be used in research to identify and characterise malignant cells.
